PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2

Nature Cell Biology

Volumn 4, Issue 11, 2002, Pages 865-870

  Yang, Shutong ^a   Kuo, Christin ^a   Bisi, John E ^b   Kim, Myung K ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; PHOSPHOTRANSFERASE; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REGULATORY MECHANISM;

ADENOVIRIDAE; APOPTOSIS; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA DAMAGE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROPORATION; GAMMA RAYS; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PLASMIDS; PRECIPITIN TESTS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; SERINE; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; U937 CELLS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0036847998     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb869     Document Type: Article

References (40)

1. de The, H. et al. The PML-RAR α fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684 (1991).
2. Goddard, A. D., Borrow, J., Freemont, P. S. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374 (1991).
3. Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR α with a novel putative transcription factor, PML. Cell 66, 663-674 (1991).
4. Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G. & Chang, K. S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14, 6858-6867 (1994).
5. Mu, Z. M., Le, X. F., Vallian, S., Glassman, A. B. & Chang, K. S. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18, 2063-2069 (1997).
6. Le, X. F., Vallian, S., Mu, Z. M., Hung, M. C. & Chang, K. S. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16, 1839-1849 (1998).
7. He, D. et al. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res. 57, 1868-1872 (1997).
8. Wang, Z. G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551 (1998).
9. Zhong, S. et al. A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941-7947 (1999).
10. Wang, Z. G. et al. PML is essential for multiple apoptotic pathways. Nature Genet 20, 266-272 (1998).
11. Quignon, F. et al. PML induces a novel caspase-independent death process. Nature Genet. 20, 259-265 (1998).
12. Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672 (1996).
13. Matsuoka, S., Huang, M. & Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-1897 (1998).
14. Brown, A. L. et al. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl Acad. Sci. USA 96, 3745-3750 (1999).
15. Hirao, A. et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827 (2000).
16. Chehab, N. H., Malikzay, A., Appel, M. & Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14, 278-288 (2000).
17. Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y. & Prives, C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289-300 (2000); erratum in Genes Dev, 14, 750 (2000).
18. Ruiter, G. A., Zerp, S. F., Bartelink, H., van Blitterswijk, W. J. & Verheij, M. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res. 59, 2457-2463 (1999).
19. Merritt, A. J., Allen, T. D., Potten, C. S. & Hickman, J. A. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation. Oncogene 14, 2759-2766 (1997).
20. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells through p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339 (1994).
21. Tamura, T. et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596-599 (1995).
22. Bartek, J., Falck, J. & Lukas, J. CHK2 kinase - a busy messenger. Nature Rev. Mol. Cell Biol. 2, 877-886 (2001).
23. Lee, J. S., Collins, K. M., Brown, A. L., Lee, C. H. & Chung, J. H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201-204 (2000).
24. Fagioli, M. et al. Alternative splicing of PML transcripts predicts co-expression of several carboxy-terminally different protein isoforms. Oncogene 7, 1083-1091 (1992).
25. Nason-Burchenal, K. et al. Interferon augments PML and PML/RAR α expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. Blood 88, 3926-3936 (1996).
26. Guidez, F. et al. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML-and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91, 2634-2642 (1998).
27. Bartkova, J. et al. Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene 20, 5897-5902 (2001).
28. Lukas, C. et al. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res. 61, 4990-4993 (2001).
29. Falck, J., Mailand, N., Syljuasen, R. G., Bartek, J. & Lukas, J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-847 (2001).
30. Wu, X., Webster, S. R. & Chen, J. Characterization of tumor-associated Chk2 mutations. J. Biol. Chem. 276, 2971-2974 (2000).
31. Ward, I. M., Wu, X. & Chen, J. Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J. Biol. Chem. 276, 47755-47758 (2001).
32. Sugimoto, K. et al. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79, 2378-2383 (1992).
33. Wolf, D. & Rotter, V. Major deletions in the gene encoding the p53 tumour antigen cause lack of p53 expression in HL-60 cells. Proc. Natl Acad. Sci. USA 82, 790-794 (1985).
34. Gotoh, T., Oyadomari, S., Mori, K. & Mori, M. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J. Biol. Chem. 277, 12343-12350 (2002).
35. Guidarelli, A., Clementi, E., De Nadai, C., Bersacchi, R. & Cantoni, O. TNFα enhances the DNA single-strand breakage induced by the short-chain lipid hydroperoxide analogue tert-butylhydroperoxide through ceramide-dependent inhibition of complex III followed by enforced superoxide and hydrogen peroxide formation. Exp. Cell Res. 270, 56-65 (2001).
36. Orengo, G. et al. Potentiation of topoisomerase I and II inhibitors cell killing by tumour necrosis factor: relationship to DNA strand breakage formation. Jpn J. Cancer Res. 83, 1132-1136 (1992).
37. Zhong, S. et al. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J. Exp. Med. 191, 631-640 (2000).
38. Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528-2531 (1999).
39. Guo, A. et al. The function of PML in p53-dependent apoptosis. Nature Cell Biol. 2, 730-736 (2000).
40. Cogswell, J. P., Brown, C. E., Bisi, J. E. & Neill, S. D. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. Cell Growth Differ 11, 615-623 (2000).